Oncology Cardiology / Cardiovascular Respiratory / COPD / Asthma Infectious Disease Gastroenterology Neurology Rheumatology Diabetes / Metabolic Mental Health / Psychiatry Women's Health Dermatology Men's Health Rare Diseases
Clinical Trial ● Currently Recruiting NCT06292299

The PARS Study: Paediatric Advanced Respiratory Service Study – An Observational Diagnostic Feasibility Study

The PARS Study: Paediatric Advanced Respiratory Service Study – An Observational Diagnostic Feasibility Study — Recruiting • Respiratory / COPD / Asthma • NCT06292299.

📅 14 Apr 2026 ⏱ 3 min read
Currently Recruiting
This trial is actively seeking participants in the UK. Discuss eligibility with your patient before referring.
Status
Currently Recruiting
NCT ID
NCT06292299
Sponsor
NHS Greater Clyde and Glasgow
Start
2024-03-01
ClinicaliQ Trial Snapshot
  • The PARS Study: Paediatric Advanced Respiratory Service Study – An Observational Diagnostic Feasibility Study — Recruiting • Respiratory / COPD / Asthma • NCT06292299.
  • Sponsor: NHS Greater Clyde and Glasgow.

Verify eligibility, endpoints and current status on the original source registry before acting on this summary.

Use This Page For
  • Quick orientation before opening the registry record.
  • Checking recruitment status, phase and sponsor at a glance.
  • Connecting this trial to nearby guidelines, Drug Science and education.
What This Trial Is Studying

Diagnostic investigations in paediatric respiratory and sleep medicine are often challenging due to patient size (due to prematurity), tolerability, and compliance with "gold standard equipment". Children with sensory/behavioural issues, at increased risk of sleep disordered breathing (SDB), often find tolerating standard diagnostic equipment difficult. There is a need to develop non-invasive, wireless, devices designed for the paediatric population. Devices must address health in-equalities as high-risk children, with low birth weights, genetic syndromes, or complex neuro-disabilities, are often unable to undergo current investigations, particularly in sleep medicine. Prompt and accurate diagnosis…

Eligibility Snapshot
  • : Group 1 - CR-poly group * Patient undergoing overnight CR-poly * Age birth to >=16 years * Are willing and able to give informed assent/consent or have available next of Kin to provide informed consent on the participant's behalf * Able (in the Investigators opinion) to comply with all study requirements * Can speak and read English Group 2 - Apnoea group * Inpatient in neonatal unit * Age birth (from 30 weeks gestational age) to term corrected * Parents willing and able to give informed consent * Able (in the Investigators opinion) to comply with all study requirements * Can speak and read English Group 3- VT Group attending epilepsy monitoirng unit * Inpatient receiving video-telemetry epilepsy monitoring unit * Age birth to

Use the source registry for the full inclusion and exclusion criteria before discussing referral or enrolment.

Full Trial Details
View this trial on the source registry
Eligibility criteria, protocol, and results when available
View Trial ↗
Share: Twitter/X LinkedIn
Related

Related Clinical Intelligence

Guidelines, Drug Science, safety briefs and education connected to this trial area.

Clinical Brief
Cuba’s mothers-to-be prepare to give birth in a country plunged into darkness
Respiratory / COPD / Asthma · BBC Health · 24 Mar 2026
Two pregnant women tell the BBC's Will Grant of their hopes and fears as their nation is mired in crisis. This update…
View brief →
Clinical Brief
Norovirus cases remain high while respiratory viruses fall
Respiratory / COPD / Asthma · UKHSA · 05 Mar 2026
Norovirus circulation remains elevated despite seasonal decline in respiratory viruses, warranting continued vigilance for gastroenteritis outbreaks in healthcare and community settings Respiratory…
View brief →
Clinical Brief
Short-acting beta 2 agonists (SABA) (salbutamol and terbutaline): reminder of the risks from overuse in asthma and to be aware of changes in the SABA prescribing guidelines
Respiratory / COPD / Asthma · MHRA · 24 Apr 2025
Healthcare professionals and patients are reminded of the risk of severe asthma attacks and increased mortality associated with overuse of SABA with…
View brief →
Clinical Brief
Rogue sperm donor who says he’s fathered 180 children won’t be on child’s birth certificate
Respiratory / COPD / Asthma · BBC Health · 21 Apr 2026
A rogue sperm donor case highlights the legal vulnerability of recipients using unregulated private donation arrangements, where donors may not be excluded…
View brief →
Guideline
Digital technologies for applying algorithms to spirometry to support asthma and COPD diagnosis in primary care and community diagnostic centres: early-use assessment
Respiratory / COPD / Asthma · 02 Apr 2026
Digital spirometry algorithms can improve diagnostic accuracy for asthma and COPD in primary care and community diagnostic centres, potentially reducing unnecessary referrals…
View guideline →
Guideline
2021 ESCMID Guidelines for the Management of Community-acquired Pneumonia
Respiratory / COPD / Asthma · 30 Mar 2026
This ESCMID guideline addresses 2021 ESCMID Guidelines for the Management of Community-acquired Pneumonia in Respiratory / COPD / Asthma. Use it to…
View guideline →